Prime Therapeutics Acquires Magellan Rx Management
Prime Therapeutics acquired Magellan Rx Management for $1.4B. View deal terms, timeline, and press on Fsome.
Deal Details
- Acquirer
- Prime Therapeutics
- Acquired Company
- Magellan Rx Management
- Price
- $1.4B
- Acquisition Type
- Acquisition
- Announced
- May 5, 2022
Canonical: https://fsome.com/acquisitions/prime-therapeutics-acquires-magellan-rx-management-8216380 · For the full deal terms, timeline, and press references, please enable JavaScript.